Hemorrhoids. Hemorrhoids and perianal venous thrombosis
Conditions
Interventions
Intervention 1: Intervention group: Daflon group: After inclusion patients consume Daflon 500mg, which is produced Amin pharmaceutical company and comprise flavonoid agents by tablet each 12 hours (ev
Sponsors
Karaj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients over the age of 18 years old who were diagnosed with grade 3 or 4 of hemorrhoids based on a surgeons' physical exam and history taking
Exclusion criteria
Exclusion criteria: Does not have a history of previous treatment of hemorrhoids. Does not have a history of consumption or allergy to Daflon tablet. Does not have a history of renal failure or electrolytes imbalance. Does not have a serious underlying disease, including immunodeficiency disease, hyperparathyroidism, complete heart block, addison's disease, intestinal disorders, or malignancies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of improvements of sign and symptoms. Timepoint: 4 weeks after inclusion. Method of measurement: Duration of times that takes for patients for their signs to get improved.;Severity of sign and symptoms. Timepoint: 4 weeks after inclusion. Method of measurement: The severity of symptoms are going to get reported by patients 4 weeks after inclusion based on visual Analogue scale.;Relapse of sign and symptoms. Timepoint: 4 weeks after inclusion. Method of measurement: In case of resolution of symptoms in 4 weeks, patients report relapse of their symptoms. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohsen Karimian
Karaj University of Medical Sciences
Outcome results
None listed